Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001493152-25-020322

Chief Executive Officer gave up 169,439 shares (to pay taxes)

  • Chief Executive Officer acquired 200,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KUMAR AMIT · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-30 Exercise or conversion : show line 1 in the form +200,000 $2.92 $584,000 779,925 D
2025-10-30 Shares withheld for taxes : show line 2 in the form −169,439 $4.06 $687,922 610,486 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-30 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −200,000 0 D
Loading xslF345X05/ownership.xml…